Appears On
Episode Appearances
MIT Technology Review Narrated · Apr 15, 2026
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
“Expert raising ethical concerns about testing multiple gene therapies on small healthy populations without longevity evidence”
Gene therapy regulation and special economic zonesVEGF (vascular endothelial growth factor) therapy safety and efficacyFollistatin gene therapy for muscle growth
View Analysis